Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system

References

• Thomas BJ, Finnin BC. The transdermal revolution. Drug Discov Today. 2004;9:697–703.
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2012;64:128–137.
   Web of Science ®Google Scholar
• Sharma A, Saini S, Rana A. Transdermal drug delivery system: a review. Skin. 2012;4:18–19.
   Google Scholar
• Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26:1261–1268.
   PubMed Web of Science ®Google Scholar
• Lee J, Seo JH, Kim D-H. Determination of tizanidine in human plasma by gas chromatography–mass spectrometry. Analyst. 2002;127:917–920.
   PubMed Web of Science ®Google Scholar
• Meythaler JM, Guin-Renfroe S, Johnson A, et al. Prospective assessment of tizanidine for spasticity due to acquired brain injury. Arch Phys Med Rehabil. 2001;82:1155–1163.
   PubMed Web of Science ®Google Scholar
• Saper JR, Lake AE, Cantrell DT, et al. Chronic daily headache prophylaxis with tizanidine: a double‐blind, placebo‐controlled, multicenter outcome study. Headache. 2002;42:470–482.
   PubMed Web of Science ®Google Scholar
• Sweetman S, Blake P, McGlashan J, et al. Antiepileptics. Martindale, “the complete drug reference”. 36th ed. London (UK): Pharmaceutical Press; 2009. p. 465–516.
   Google Scholar
• Malanga G, Reiter RD, Garay E. Update on tizanidine for muscle spasticity and emerging indications. Expert Opin Pharmacother. 2008;9(12):2209–2215.
   Google Scholar
• Mutalik S, Parekh HS, Davies NM, et al. A combined approach of chemical enhancers and sonophoresis for the transdermal delivery of tizanidine hydrochloride. Drug Deliv. 2009;16:82–91.
   PubMed Web of Science ®Google Scholar
• Arora P, Mukherjee B. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J Pharm Sci. 2002;91:2076–2089.
   PubMed Web of Science ®Google Scholar
• Azim AA, El-Ashmoony M, Swealem A, et al. Transdermal films containing tizanidine: in vitro and in vivo evaluation. J Drug Deliv Sci Technol. 2014;24:92–99.
   Web of Science ®Google Scholar
• Ali T, Shoaib MH, Yousuf RI, Siddiqui, F, et al. Development and validation of a reverse phase high performance liquid chromatography (HPLC) method for determination of tizanidine in human plasma. Afr J Pharm Pharmacol. 2014;8:199–205.
   Google Scholar
• Gannu R, Vamshi Vishnu Y, Kishan V, et al. Development of nitrendipine transdermal patches: in vitro and ex vivo characterization. CDD. 2007;4:69–76.
   PubMedGoogle Scholar
• Barhate SD, Patel M, Sharma AS, et al. Formulation and evaluation of transdermal drug delivery system of carvedilol. Int J Contemp Microbiol. 2016;9:2127.
   Google Scholar
• Ammar H, Ghorab M, El-Nahhas S, et al. Polymeric matrix system for prolonged delivery of tramadol hydrochloride. Part I: physicochemical evaluation. AAPS PharmSciTech. 2009;10:7–20.
   PubMed Web of Science ®Google Scholar
• Mutalik S, Udupa N. Glibenclamide transdermal patches: physicochemical, pharmacodynamic, and pharmacokinetic evaluations. J Pharm Sci. 2004;93:1577–1594.
   PubMed Web of Science ®Google Scholar
• Ubaidulla U, Reddy MV, Ruckmani K, et al. Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS PharmSciTech. 2007;8:E13–E20.
   PubMed Web of Science ®Google Scholar
• Prajapati ST, Patel CG, Patel CN. Formulation and evaluation of transdermal patch of repaglinide. ISRN Pharm. 2011;2011:1.
   Google Scholar
• John L, Kumar A, Samuel S. Formulation and in vitro evaluation of indomethacin transdermal patches using polymers HPMC e5 and ethyl cellulose. Int Res J Pharm. 2013;4:84–556.
   Google Scholar
• Saroha K, Yadav B, Sharma B. Transdermal patch: a discrete dosage form. Int J Curr Pharm Sci. 2016;9:132–108.
   Google Scholar
• Madishetti S, Palem C, Gannu R, et al. Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization. Daru. 2010;18:221.
   PubMed Web of Science ®Google Scholar
• Mamatha T, Rao JV, Mukkanti K, et al. Development of matrix type transdermal patches of lercanidipine hydrochloride: physicochemical and in-vitro characterization. Daru. 2010;18:9.
   PubMed Web of Science ®Google Scholar
• McCarthy LG, Kosiol C, Healy AM, et al. Simulating the hydrodynamic conditions in the United States Pharmacopeia paddle dissolution apparatus. AAPS PharmSciTech. 2003;4:83–98.
   Google Scholar
• Panchagnula R, Salve PS, Thomas NS, et al. Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int J Pharm. 2001;219:95–105.
   PubMed Web of Science ®Google Scholar
• Davaran S, Rashidi MR, Khandaghi R, et al. Development of a novel prolonged-release nicotine transdermal patch. Pharmacol Res. 2005;51:233–237.
   PubMed Web of Science ®Google Scholar
• Melero A, Garrigues T, Almudever P, et al. Nortriptyline hydrochloride skin absorption: development of a transdermal patch. Eur J Pharm Biopharm. 2008;69:588–596.
   PubMed Web of Science ®Google Scholar
• Satheeshababu B, Shruthinag R. Synthesis and characterisation of chitosan conjugate; design and evaluation of membrane moderated type transdermal drug delivery system. Indian J Pharm Sci. 2015;77:405.
   PubMed Web of Science ®Google Scholar
• Dangi AA, Sheth ZP, Janki J. Formulation and evaluation of transdermal ondansetron hydrochloride matrix patch: in vitro skin permeation and irritation study. Int J Pharm Res Allied Sci. 2012;1(2):26–34.
   Google Scholar
• Sonjoy M, Thimmasetty J, Ratan G, et al. Formulation and evaluation of carvedilol transdermal patches. Int Res J Pharm. 2011;2:237–248.
   Google Scholar
• Bharkatiya M, Nema RK, Bhatnagar M. Development and characterization of transdermal patches of metoprolol tartrate. Development. 2010;3:130–134.
   Google Scholar
• Rahman MM, Islam MS, Sharmin N, et al. Preparation and evaluation of cellulose acetate phthalate and ethyl cellulose based microcapsules of diclofenac sodium using emulsification and solvent-evaporation method. Dhaka Univ J Pharm Sci. 2011;9:39–46.
   Google Scholar
• Nussinovitch A, Gal A, Padula C, et al. Physical characterization of a new skin bioadhesive film. AAPS PharmSciTech. 2008;9:458–463.
   PubMed Web of Science ®Google Scholar
• Prabhakar D, Aparna C, Shastri N, et al. Development of transdermal patches for Bisoprolol fumarate. J Pharm Res. 2012;5:1338–1341.
   Google Scholar
• Piorkowska E, Kulinski Z, Galeski A, et al. Plasticization of semicrystalline poly(l-lactide) with poly(propylene glycol). Polymer. 2006;47:7178–7188.
   Web of Science ®Google Scholar
• Zhang X, Wang Y, Wang J, et al. Effect of pore former on the properties of casted film prepared from blends of Eudragit NE 30 D and Eudragit L 30 D-55. Chem Pharm Bull. 2007;55:1261–1263.
   PubMed Web of Science ®Google Scholar
• Moustafine RI, Zaharov IM, Kemenova VA. Physicochemical characterization and drug release properties of Eudragit® E PO/Eudragit® L 100-55 interpolyelectrolyte complexes. Eur J Pharm Biopharm. 2006;63:26–36.
   PubMed Web of Science ®Google Scholar
• Ashutosh B, Chakraborthy G, Amit B, et al. Formulation and evaluation of sustained release matrix tablet of antihypertensive drugs using hydrophobic and hydrophilic matrix polymers. Int J Pharm Erud. 2014;4:1–9.
   Google Scholar
• Gibson JW, Tipton AJ. Polymeric devices for controlled release of active agents. Google Patents; 2014.
   Google Scholar
• Biju S, Saisivam S, Rajan NMG, et al. Dual coated erodible microcapsules for modified release of diclofenac sodium. Eur J Pharm Biopharm. 2004;58:61–67.
   PubMed Web of Science ®Google Scholar
• Rahimpour A, Madaeni S. Polyethersulfone (PES)/cellulose acetate phthalate (CAP) blend ultrafiltration membranes: preparation, morphology, performance and antifouling properties. J Membr Sci. 2007;305:299–312.
   Web of Science ®Google Scholar
• Siepmann J, Peppas NA. Mathematical modeling of controlled drug delivery. Adv Drug Deliv Rev. 2001;48:137–138.
   PubMed Web of Science ®Google Scholar
• Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123–133.
   PubMed Web of Science ®Google Scholar
• Emre M, Leslie G, Muir C, et al. Correlations between dose, plasma concentrations, and antispastic action of tizanidine (Sirdalud). J Neurol Neurosurg Psychiatry. 1994;57:1355–1359.
   PubMed Web of Science ®Google Scholar